Takeda Yusuke, Matoba Keiichiro, Sekiguchi Kensuke, Nagai Yosuke, Yokota Tamotsu, Utsunomiya Kazunori, Nishimura Rimei
Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.
Center for Preventive Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.
Biomedicines. 2020 Jun 29;8(7):182. doi: 10.3390/biomedicines8070182.
Diabetes is a worldwide health issue closely associated with cardiovascular events. Given the pandemic of obesity, the identification of the basic underpinnings of vascular disease is strongly needed. Emerging evidence has suggested that endothelial dysfunction is a critical step in the progression of atherosclerosis. However, how diabetes affects the endothelium is poorly understood. Experimental and clinical studies have illuminated the tight link between insulin resistance and endothelial dysfunction. In addition, macrophage polarization from M2 towards M1 contributes to the process of endothelial damage. The possibility that novel classes of anti-hyperglycemic agents exert beneficial effects on the endothelial function and macrophage polarization has been raised. In this review, we discuss the current status of knowledge regarding the pathological significance of insulin signaling in endothelium. Finally, we summarize recent therapeutic strategies against endothelial dysfunction with an emphasis on macrophage polarity.
糖尿病是一个与心血管事件密切相关的全球性健康问题。鉴于肥胖症的流行,迫切需要确定血管疾病的基本病因。新出现的证据表明,内皮功能障碍是动脉粥样硬化进展的关键步骤。然而,糖尿病如何影响内皮细胞尚不清楚。实验和临床研究揭示了胰岛素抵抗与内皮功能障碍之间的紧密联系。此外,巨噬细胞从M2向M1的极化有助于内皮损伤过程。新型抗高血糖药物对内皮功能和巨噬细胞极化产生有益作用的可能性已被提出。在这篇综述中,我们讨论了关于胰岛素信号在内皮细胞中的病理意义的当前知识状态。最后,我们总结了针对内皮功能障碍的最新治疗策略,重点是巨噬细胞极性。